
1. parasitol res. 2019 mar;118(3):1011-1018. doi: 10.1007/s00436-019-06210-3. epub
2019 jan 31.

effects mao-a cyp450 primaquine metabolism healthy volunteers.

ariffin nm(1), islahudin f(2), kumolosasi e(1), makmor-bakry m(1).

author information: 
(1)faculty pharmacy, jalan raja muda abdul aziz, abdul aziz, 50300, kuala
lumpur, malaysia.
(2)faculty pharmacy, jalan raja muda abdul aziz, abdul aziz, 50300, kuala
lumpur, malaysia. faridaislahudin@yahoo.com.

eliminating plasmodium vivax malaria parasite infection remains challenging. 
one main problems capacity form hypnozoites potentially
lead recurrent infections. present, primaquine drug used for
the management hypnozoites. however, effects primaquine may differ from
one individual another. aim work determine new measures to
reduce p. vivax recurrence, primaquine metabolism host genetics. a
genetic study mao-a, cyp2d6, cyp1a2 cyp2c19 roles primaquine 
metabolism undertaken healthy volunteers (n = 53). elimination rate
constant (ke) metabolite-to-parent drug concentration ratio (cm/cp) 
obtained assess primaquine metabolism. allelic genotypic analysis showed
that polymorphisms mao-a (rs6323, 891g>t), cyp2d6 (rs1065852, 100c>t) cyp2c19
(rs4244285, 19154g>a) significantly influenced primaquine metabolism. cyp1a2
(rs762551, -163c>a) influence primaquine metabolism. haplotypic
analysis, significant differences ke (p = 0.00) cm/cp (p = 0.05) were
observed individuals polymorphisms, gg-mao-a (891g>t), ct-cyp2d6
(100c>t) gg-cyp2c19 (19154g>a), individuals polymorphisms, tt-mao-a 
(891g>t), tt-cyp2d6 (100c>t) aa-cyp2c19 (19154g>a), well polymorphisms,
gg-mao-a (891g>t), tt-cyp2d6 (100c>t) ga-cyp2c19 (19154g>a). thus,
individuals cyp2d6 polymorphisms slower primaquine metabolism activity. 
the potential significance genetic roles primaquine metabolism and
exploration might help optimise management p. vivax
infection.

doi: 10.1007/s00436-019-06210-3 
pmid: 30706164  [indexed medline]

